ANIMAL EXPERIMENT;
ANTICONVULSANT ACTIVITY;
ANTIPSYCHOTIC ACTIVITY;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
INFRARED RADIATION;
MASS SPECTROMETRY;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
RAT;
ROTAROD TEST;
A trial on chronic schizophrenic patient of oxypertine, a psychtropic drug with an indole ring
Durell J., Pollin W., A Trial on Chronic Schizophrenic Patient of Oxypertine, a psychtropic Drug with an Indole Ring, The Brit. J. Psychiatry 1963, 109, 687-691.
Synthesis of some new benzothia/ oxazepinyl indoles as an antipsychotic agents
Bajaj K., Srivastava V. K., Lata S., Chandra R., Kumar A., Synthesis of some new benzothia/ oxazepinyl indoles as an antipsychotic agents. Indian J. Chem., 42B, 1723-1728.
Synthesis, anticonvulsant and toxicity evaluation of 2 (1Hindol- 3-yl)acetyl-N-(Substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives
Siddiqui N., Ahsan M. S. A. W., Synthesis, anticonvulsant and toxicity evaluation of 2 (1Hindol- 3-yl)acetyl-N-(Substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives Acta Pharm. 2008, 58, 445-454.
Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1, 2, 4- oxadiazolyl)-phenyl)carboxamido)cyclohexyl) ethyl)-7-methylsulphonyl-2,3,4,5-tetrahydro-1H-3- benzazepine SB-414796): A potent and selective dopamine d3 receptor antagonist
Macdonaled G.J., Branch C.L., Hadley M.D., Johnson C. N., Nash D.J., Smith A. B., G. Stemp, K. M. Thewlis, A. K. K. Vong, N.E. Austin, P. Jeffrey, K. Y. Winborn, I. Boyfield, Hagan J.J., Middlemiss D.N., Reavill C., Riley G.J., Watson J.M., Wood M., Parker S.G., Ashby C.R., Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1, 2, 4- oxadiazolyl)-phenyl)carboxamido)cyclohexyl) ethyl)-7-methylsulphonyl-2,3,4,5-tetrahydro-1H-3- benzazepine SB-414796): A potent and selective dopamine d3 receptor antagonist. J. Med. Chem. 2003, 46, 4952-4964.
Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)-6(3-propylthio-1,3,5-thiadiazol- 4-yl)- 1-azabicyclo[3.2.1]octane
Bymaster F. P.; Shannon H. E.; Rasmussen K.; Delapp N. W., Mitch C. H., Ward J. S., Calligaro D.O., Ludvigsen T. S., Sheardown M.J., Olesen P. H., Swedberg M. D., Sauerberg P., Fink J. A., Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)-6(3-propylthio-1,3,5-thiadiazol- 4-yl)- 1-azabicyclo[3.2.1]octane, Eur. J. Pharmacol.1998, 356 (2-3), 109-119.
Synthesis an anticonvulsant activity of new 2- Substituted-5-[2-fluorophenoxy)phenyl]-1,3,4- oxadiazoles and 1,2,4-triazoles
Almasirad A., Tabatabai S.A., Faizi M., Kebriacezadch A., Mehrabi N., Dalvandi A., Shafiee A., Synthesis an anticonvulsant activity of new 2- Substituted-5-[2-fluorophenoxy)phenyl]-1,3,4- oxadiazoles and 1,2,4-triazoles, Bio. Med. Chem. Lett. 2004, 14, 6057-6059.
Synthesis of new 2,5-Disubstituted-,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities
Dogan H.N., Duran A., Rollas S., Sener G., Uysal M.K., Gulen D., Synthesis of new 2,5-Disubstituted-,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities. Bio. Med.Chem. 2002, 10, 2893-2898.
Synthesis of newer indolylthiadiazoles and their thiazolidinones and formazans as potent anticonvulsant agents
Archana, Srivastava V.K., Kumar A., Synthesis of newer indolylthiadiazoles and their thiazolidinones and formazans as potent anticonvulsant agents. Indian J. Pharm. Sci.; 2003, 65, 358-365.
Synthesis and biological activity of some new 10- [(3,5diaryl-2-pyrazolin-1-yl)acetyl]phenothiazines
Jaiswal N., Jaiswal R. K., Barthwal J. P., Kishor K., Synthesis and biological activity of some new 10- [(3,5diaryl-2-pyrazolin-1-yl)acetyl]phenothiazines. Indian J. Chem. 1981, 20B (3), 252-253.
Synthesis and binding affinity of new pyrazole & isoxazole derivatives as potential antipsychotic atypical antipsychotics
Bercelo M., Ravina E., Masaquer C. F., Dominquez E., Areias F. M., Brea J., Loza M.I., Synthesis and binding affinity of new pyrazole & isoxazole derivatives as potential antipsychotic atypical antipsychotics. Bio. Med. Chem. Lett. 2007, 17 (17) 4873-4877.
Synthesis and biological evaluation of 1-(1,2-benzoisothiazol-3- yl)-and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents
Yevich J. P., New J. S., Smith D.W., Lobeck G. W., Catt J. D., Minielli J.L, Eison MS., Taylor F. P., Riblet L. A., Temple D. L. Jr., Synthesis and biological evaluation of 1-(1,2-benzoisothiazol-3- yl)-and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents. J. Med. Chem; 1986, 29 (3), 359-369.
Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)- pyrazoline derivatives
Ozdemir Z., Kandilci H. B., Gumusel B., Calis U. A., Bilgin A., Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)- pyrazoline derivatives. Eur. J. Med. Chem. 2007, 47, 373-379.
Properties of maximal seizures and their alternation by anticonvulsant drugs and other agents
Toman J.E.P., Swinyard E. A., Goodman L.S.; Properties of maximal seizures and their alternation by anticonvulsant drugs and other agents; J. Neurophysiol. 1946, 231-240.
